杭州九源基因生物医药股份有限公司（02566）于2026年2月6日发布公告，披露当日回购H股79,200股，占回购前已发行股份的约0.07495%。本次回购价格介乎每股9.88港元至10港元，合计支付约790,449.98港元。
经本次回购后，公司已发行股份（不包括库存股份）数目变更为105,594,985股，库存股份增至3,501,800股。公司于2025年6月11日通过的购回授权总数为10,909,678股，截至目前已回购股份合计3,501,800股。
公司确认本次回购已依据董事会授权，并遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由联席公司秘书黄秀签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.